HEADER HYDROLASE 25-JUL-04 1W4L TITLE COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE KEYWDS ALZHEIMER'S DISEASE, CHOLINESTERASE, GLYCOPROTEIN, GPI-ANCHOR, KEYWDS 2 HYDROLASE, MUSCLE, NERVE, NEUROTRANSMITTER DEGRADATION, SERINE KEYWDS 3 ESTERASE, SERINE HYDROLASE, SYNAPSE EXPDTA X-RAY DIFFRACTION AUTHOR H.M.GREENBLATT,C.GUILLOU,D.GUENARD,B.BADET,C.THAL,I.SILMAN, AUTHOR 2 J.L.SUSSMAN REVDAT 6 06-NOV-24 1W4L 1 HETSYN REVDAT 5 29-JUL-20 1W4L 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 10-APR-19 1W4L 1 JRNL REVDAT 3 03-APR-19 1W4L 1 REMARK LINK REVDAT 2 24-FEB-09 1W4L 1 VERSN REVDAT 1 25-NOV-04 1W4L 0 JRNL AUTH H.M.GREENBLATT,C.GUILLOU,D.GUENARD,A.ARGAMAN,S.BOTTI, JRNL AUTH 2 B.BADET,C.THAL,I.SILMAN,J.L.SUSSMAN JRNL TITL THE COMPLEX OF A BIVALENT DERIVATIVE OF GALANTHAMINE WITH JRNL TITL 2 TORPEDO ACETYLCHOLINESTERASE DISPLAYS DRASTIC DEFORMATION OF JRNL TITL 3 THE ACTIVE-SITE GORGE: IMPLICATIONS FOR STRUCTURE-BASED DRUG JRNL TITL 4 DESIGN. JRNL REF J.AM.CHEM.SOC. V. 126 15405 2004 JRNL REFN ISSN 0002-7863 JRNL PMID 15563167 JRNL DOI 10.1021/JA0466154 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.MARY,D.Z.RENKO,C.GUILLOU,C.THAL REMARK 1 TITL POTENT ACETYLCHOLINESTERASE INHIBITORS: DESIGN, SYNTHESIS, REMARK 1 TITL 2 AND STRUCTURE-ACTIVITY RELATIONSHIPS OF BIS-INTERACTING REMARK 1 TITL 3 LIGANDS IN THE GALANTHAMINE SERIES REMARK 1 REF BIOORG.MED.CHEM. V. 6 1835 1998 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 9839013 REMARK 1 DOI 10.1016/S0968-0896(98)00133-3 REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2157149.210 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 52748 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2636 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4844 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 255 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4204 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 309 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.31000 REMARK 3 B22 (A**2) : 7.31000 REMARK 3 B33 (A**2) : -14.63000 REMARK 3 B12 (A**2) : 5.71000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.10 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.12 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.022 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.260 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.240 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.810 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.930 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.890 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 57.53 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1W4L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUL-04. REMARK 100 THE DEPOSITION ID IS D_1290020545. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52750 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.21000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLISED FROM 35-40% REMARK 280 W/V PEG 200 0.1M MES PH 5.8 4 DEG. CELSIUS, PH 5.50, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.61967 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.23933 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.23933 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.61967 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 136.85900 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 486 REMARK 465 SER A 487 REMARK 465 GLN A 488 REMARK 465 ALA A 536 REMARK 465 CYS A 537 REMARK 465 ASP A 538 REMARK 465 GLY A 539 REMARK 465 GLU A 540 REMARK 465 LEU A 541 REMARK 465 SER A 542 REMARK 465 SER A 543 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 49 CG CD OE1 OE2 REMARK 470 GLU A 89 CD OE1 OE2 REMARK 470 LYS A 192 CG CD CE NZ REMARK 470 GLU A 350 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG LEU A 452 O HOH A 2272 2.17 REMARK 500 NE ARG A 468 O HOH A 2277 2.17 REMARK 500 NE ARG A 47 O HOH A 2021 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2002 O HOH A 2182 3564 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 82 CB GLU A 82 CG 0.123 REMARK 500 MET A 175 SD MET A 175 CE -0.457 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 22 CB - CA - C ANGL. DEV. = -13.0 DEGREES REMARK 500 VAL A 129 CB - CA - C ANGL. DEV. = -12.6 DEGREES REMARK 500 LEU A 143 CA - CB - CG ANGL. DEV. = -14.1 DEGREES REMARK 500 ARG A 243 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 243 NE - CZ - NH2 ANGL. DEV. = -6.0 DEGREES REMARK 500 VAL A 518 CB - CA - C ANGL. DEV. = -14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -156.59 -134.60 REMARK 500 PHE A 45 -13.84 82.08 REMARK 500 CYS A 94 13.98 -141.91 REMARK 500 SER A 108 79.91 -160.44 REMARK 500 ALA A 164 72.79 -150.23 REMARK 500 SER A 200 -114.57 56.80 REMARK 500 GLU A 299 -75.97 -125.93 REMARK 500 THR A 317 -159.43 -159.96 REMARK 500 ASP A 326 66.10 -119.21 REMARK 500 ASP A 380 52.82 -160.75 REMARK 500 VAL A 400 -60.32 -128.02 REMARK 500 ASN A 506 -169.08 -164.68 REMARK 500 GLN A 526 -56.49 -122.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N, REMARK 900 N-TRIMETHYLAMMONIO) TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O- ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE REMARK 900 AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 ) FROM TORPEDO REMARK 900 CALIFORNICA AT 1.8A RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- ALZHEIMER DRUG, E2020 REMARK 900 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- II REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH (+)-HUPERZINE A AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT REMARK 900 2.35A RESOLUTION REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH RIVASTIGMINE REMARK 900 RELATED ID: 1GQS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH NAP REMARK 900 RELATED ID: 1H22 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(10)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1H23 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(12)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE REMARK 900 AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( 3- REMARK 900 TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1JGA RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7- HEPTYLENE-BIS-N,N'-SYN-2- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JGB RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3- PROPYLENE-BIS-N,N'-SYN-4- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JJB RELATED DB: PDB REMARK 900 A NEUTRAL MOLECULE IN CATION-BINDING SITE: SPECIFIC BINDINGOF PEG- REMARK 900 SH TO ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1ODC RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 4'-QUINOLYL-N'-9 "-(1",2",3",4"-TETRAHYDROACRIDINYL)-1,8- REMARK 900 DIAMINOOCTANE AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT REMARK 900 GD (SOMAN). REMARK 900 RELATED ID: 1UT6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 9-(1',2',3',4 '-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT 2.4 REMARK 900 ANGSTROMS RESOLUTION. REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W75 RELATED DB: PDB REMARK 900 NATIVE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE (ACHE) REMARK 900 RELATED ID: 1W76 RELATED DB: PDB REMARK 900 ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 COMPLEXED WITH BIS- ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- PHOSPHORO-FLUORIDATE (DFP) REMARK 900 BOUND TO ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 999 REMARK 999 SEQUENCE REMARK 999 FIRST THREE N-TERMINAL RESIDUES AND LAST 8 C-TERMINAL REMARK 999 RESIDUES NOT SEEN IN DENSITY, AND NOT INCLUDED IN REMARK 999 COORDINATE FILE. RESIDUES 486-489 HAVE POOR DENSITY, AND REMARK 999 ARE NOT MODELED. DBREF 1W4L A 1 543 UNP P04058 ACES_TORCA 22 564 SEQRES 1 A 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER MODRES 1W4L ASN A 59 ASN GLYCOSYLATION SITE MODRES 1W4L ASN A 416 ASN GLYCOSYLATION SITE MODRES 1W4L ASN A 457 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A1536 14 HET NAG A1539 14 HET GL8 A1540 39 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GL8 GALANTHAMINE DERIVATIVE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GL8 (4AR,6S,8AR)-11-[8-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL- HETSYN 2 GL8 2-YL)OCTYL]-6-HYDROXY-3-METHOXY-5,6,9,10-TETRAHYDRO- HETSYN 3 GL8 4AH-[1]BENZOFURO[3A,3,2-EF][2]BENZAZEPIN-11-IUM FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 5 GL8 C32 H37 N2 O5 1+ FORMUL 6 HOH *309(H2 O) HELIX 1 1A SER A 79 ASN A 85 1 7 HELIX 2 2A GLY A 132 GLU A 139 1 8 HELIX 3 3A VAL A 168 ASN A 183 1 16 HELIX 4 4A SER A 200 LEU A 211 1 12 HELIX 5 5A VAL A 238 LEU A 252 1 15 HELIX 6 6A ASP A 259 GLU A 268 1 10 HELIX 7 7A PRO A 271 GLU A 278 1 8 HELIX 8 8A LEU A 305 SER A 311 1 7 HELIX 9 9A SER A 329 GLY A 335 1 7 HELIX 10 10A ARG A 349 VAL A 360 1 12 HELIX 11 11A ASP A 365 THR A 376 1 12 HELIX 12 12A GLY A 384 TYR A 411 1 28 HELIX 13 13A GLU A 443 PHE A 448 1 6 HELIX 14 14A ALA A 460 THR A 479 1 20 HELIX 15 15A VAL A 518 THR A 535 1 18 SHEET 1 A 3 LEU A 6 THR A 10 0 SHEET 2 A 3 GLY A 13 MET A 16 -1 N VAL A 15 O VAL A 8 SHEET 3 A 3 VAL A 57 ALA A 60 1 N TRP A 58 O LYS A 14 SHEET 1 B11 MET A 16 PRO A 21 0 SHEET 2 B11 HIS A 26 PRO A 34 -1 O ALA A 29 N THR A 18 SHEET 3 B11 TYR A 96 PRO A 102 -1 N ILE A 99 O PHE A 30 SHEET 4 B11 VAL A 142 SER A 147 -1 N LEU A 143 O TRP A 100 SHEET 5 B11 THR A 109 TYR A 116 1 N MET A 112 O VAL A 142 SHEET 6 B11 THR A 193 GLU A 199 1 O THR A 195 N VAL A 113 SHEET 7 B11 ARG A 220 SER A 226 1 N ILE A 223 O ILE A 196 SHEET 8 B11 GLN A 318 ASN A 324 1 N GLY A 322 O LEU A 224 SHEET 9 B11 GLY A 417 PHE A 423 1 N TYR A 421 O LEU A 321 SHEET 10 B11 PHE A 502 LEU A 505 1 N ILE A 503 O LEU A 420 SHEET 11 B11 MET A 510 GLN A 514 -1 N HIS A 513 O PHE A 502 SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.06 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.01 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.02 LINK ND2 ASN A 59 C1 NAG A1536 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 457 C1 NAG A1539 1555 1555 1.48 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.40 CISPEP 1 SER A 103 PRO A 104 0 0.25 CRYST1 111.327 111.327 136.859 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008983 0.005186 0.000000 0.00000 SCALE2 0.000000 0.010372 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007307 0.00000